Recent Company News

• 08:09 AM ET Apr 16, 2026
  

  Vir Biotechnology announces closing of strategic collaboration with Astellas ($10.46, 0.00)

• 11:50 PM ET Apr 14, 2026
  

  Astellas Pharma doses first patient in phase 3 study of combining ASP3082 with mFOLFIRINOX or NALIRIFOX for KRAS G12D-mutated PDAC

• 10:05 AM ET Apr 13, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 11-Apr

• 08:16 AM ET Apr 08, 2026
  

  Dyno Therapeutics (private) announces capsid license exercised by Astellas for skeletal muscle-targeted Gene delivery

• 12:20 AM ET Apr 08, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (72 total)

• 11:13 PM ET Apr 07, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (111 total)

• 11:07 PM ET Apr 01, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (65 total)

• 11:06 PM ET Apr 01, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (64 total)

• 11:35 PM ET Mar 31, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (44 total)

• 11:10 PM ET Mar 31, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (32 total)